• Direct Mouse Genotyping Kit: PCR Workflow

  2026-08-25

  The Direct Mouse Genotyping Kit supports genomic DNA release and direct PCR amplification from mouse tissue without conventional purification, simplifying routine mouse genetic screening and high-throughput genotyping. It is intended for PCR-based assays, not applications requiring highly purified DNA or unvalidated downstream enzymatic workflows.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-08-25

  This study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal-muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological screening, mass cytometry, transcriptomics, and in vivo muscle-injury models, the authors show that GSK3 inhibition suppresses fat formation while enhancing FAP support of muscle satellite-cell differentiation.

• Chlorin e6 Workflows for PDT Research

  2026-08-24

  Chlorin e6 supports controllable ROS-based experiments spanning anticancer photodynamic therapy and antibacterial wound scaffolds. This guide translates the Ce6 photosensitizer into practical formulation, irradiation, assay, and troubleshooting workflows, including the aligned silk-fibroin platform reported for infected wound healing.

• Methoxy-X04 Workflows for Amyloid Imaging

  2026-08-24

  Methoxy-X04 converts amyloid pathology into a practical fluorescent readout for plaque mapping, cerebrovascular amyloid visualization, and treatment-response studies. Its brain permeability and affinity for fibrillary Aβ make it especially useful for connecting rTMS-driven microglial clearance with measurable changes in Alzheimer’s disease models.

• Phosbind Biotin LC Western Blot Guide

  2026-08-23

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is suited to Western Blot workflows using streptavidin-HRP and chemiluminescence, but not to aqueous-only protocols or long-term storage of working solutions.

• Morin: Mechanism, Evidence, and Research Workflow

  2026-08-22

  Morin is a natural flavonoid with the systematic name 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one. Its research value combines antioxidant and inflammation-related pathway studies, reported inhibition of adenosine 5′-monophosphate deaminase, and fluorescent metal-ion detection.

• Methoxy-X04 Reveals Exercise-Linked Aβ Clearance

  2026-08-21

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for mapping plaques, oligomers, and cerebrovascular deposits in Alzheimer’s disease models. This article connects its assay logic to new evidence that muscle-derived extracellular vesicles enhance microglial amyloid clearance after exercise.

• Allosteric PDK4 Inhibitors for Metabolic Disease

  2026-08-20

  Jeon and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical lead. The study connects PDK4 inhibition with improved glucose tolerance, reduced allergic responses, and anticancer activity in preclinical models while highlighting metabolic stability, pharmacokinetics, and docking as key development considerations.

• Exercise, EVs, and Amyloid Clearance in AD Mice

  2026-08-20

  A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as a mediator of exercise-related cognitive benefit in Alzheimer’s disease mice. The work connects swimming exercise, miR-378a-3p cargo, disease-associated microglia, lipid metabolism, and amyloid-beta plaque clearance, suggesting a mechanistically defined exercise-mimicking strategy.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-08-19

  A 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that couples energy-stress adaptation to NRF2-dependent antioxidant defense. The work clarifies how lysosomal signaling, p62 phosphorylation, and metabolic context may help explain adaptation in STK11/LKB1- and KEAP1-altered lung cancer.

• JSH-23: Mechanism and NF-κB Inhibition

  2026-08-19

  JSH-23 is a small-molecule NF-κB inhibitor that suppresses p65 nuclear localization and DNA binding without blocking IκB degradation. Evidence from macrophage, airway epithelial, and cisplatin-induced acute kidney injury model studies supports its use as a mechanistic research tool, while also showing that pathway dependence varies by biological context.

• Methotrexate: Applied Folate Antagonist Workflows

  2026-08-18

  Build reproducible Methotrexate assays for DHFR inhibition, immune-cell proliferation, apoptosis, and inflammation research. A biomimetic chromatography comparison adds a practical decision framework for separating cell-based potency from membrane-partitioning and pulmonary-permeability questions.

• Parathyroid hormone (1-34) (human) in CKD Models

  2026-08-18

  Parathyroid hormone (1-34) (human) provides a defined way to activate PTH receptor signaling while connecting calcium biology with CKD-associated valvular calcification research. This guide translates the Foxp1–Notch findings into practical cell, co-culture, and in vivo workflows, with concentration, handling, and troubleshooting guidance.

• Firefly Luciferase mRNA: A Formulation-Aware Guide

  2026-08-17

  Firefly Luciferase mRNA is more than a bright reporter: its signal integrates transcript integrity, delivery, translation, and enzyme activity. This formulation-aware guide explains how ARCA capping, modified nucleotides, and lipid nanoparticle design influence assay interpretation.

• Phalloidin (B7678): F-Actin Workflow Guide

  2026-08-17

  Phalloidin (B7678) is a high-affinity F-actin probe for stabilizing and visualizing filamentous actin in fixed or permeabilized samples. It is useful for endpoint cytoskeleton analysis and morphology assays, but should not be used for live-cell imaging or experiments requiring reversible actin remodeling.

7857 records 1/524 page Next 12345 下5页 Last page